Improving Outcomes in Advanced Prostate Cancer

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: Varied

Overview

In this immersive educational program, participants will expand their understanding of managing patients with Advanced Prostate Cancer. This program utilizes the innovative AliveSim platform, offering real-life clinical case scenarios to work through in a low-stress environment with guidance from experts in the field of Oncology. Patient case scenarios created by our expert faculty will cover key oncology topics such as genetic testing, clinical treatment options and personalized care plans involving PARPi and AR directed therapy combinations. Interact with virtual patients and physicians as you practice managing Prostate cancer with expert clinical mentoring.

Target Audience

This activity is designed to educate the prostate cancer care team including oncologists, nurse practitioners, physician assistants, pharmacists, and nurse specialists.

Learning Objectives

  1. Review the latest evidence for treatment of patients in high-risk BCR and metastasis-free survival
  2. Outline the MOA and clinical utility of newer therapies for advanced prostate cancer
  3. Examine how gene mutations and predictive biomarkers impact clinical decisions
  4. Optimize management of advanced prostate cancer care and improve outcomes
  5. Identify and overcome health inequities in the identification, management, and outcomes of advanced prostate cancer

Commercial Support

This activity is supported by educational grants from Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Sun Pharmaceutical Industries, Inc.

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course opens: 
07/31/2024
Course expires: 
07/31/2025
Cost:
$0.00
Rating: 
0

Tanya Barauskas Dorff, MD

Professor
Department of Medical Oncology & Therapeutics Research
Division Chief, Genitourinary Disease Program 
City of Hope
Los Angeles, CA

 

Neal D. Shore, MD FACS

Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, SC

Conflict of Interest Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Tanya Barauskas Dorff, MD discloses that she is on an advisory board for AstraZeneca, Bayer, Janssen and Sanofi

Neal D. Shore, MD FACS discloses that he is a consultant and on an advisory board for Amgen, Astellas, AstraZeneca, Bayer, BDendreon, Ferring, Janssen

Disclosure of Unlabeled Use

Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Disclaimer

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Copyright Statement

This CME simulation activity is licensed to Horizon. Copyright © 2024 Syandus Inc and Horizon. All rights reserved. No part of this simulation activity may be reproduced without written permission from Horizon and Syandus Inc.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above